Anti-Cardiolipin Antibody in Acute Myocardial Infarction

American Journal of Animal and Veterinary Sciences

Volumn 6, Issue 1, 2010, Pages 11-14

  Jahromi, Abdolreza Sotoodeh ^a   Shojaie, Mohammad ^b   Dana, Samira ^a   Madani, Abdoulhossain ^a  

^a Department of ImmunologyJahrom University of Medical Science ^*  (Iran)

^b JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticardiolipin antibody; myocardial infarction

Indexed keywords

EID: 78049342065     PISSN: 15574555     EISSN: 15574563     Source Type: Journal    
DOI: 10.3844/ajisp.2010.11.14     Document Type: Article

References (21)

1. Antman, E.M., M. Hand, P.W. Armstrong, E.R. Bates and L.A. Green et al., 2008. Focused update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation, 117: 296-329. PMID: 18071078
2. Ferlazzo, B., D. Bonanno, P. Quattrocchi, A.M. Paino and F. Arrigo, 1993. Connection between ischemic heart disease and anticardiolipin antibodies positivity. Minerva Cardioangiol, 41: 113-117. PMID: 8332265
3. Foster, J.J. and W. Pitts, 2009. Implementation of an insulin therapy protocol: Applying the Baldrige approach. Am. J. Health Syst. Pharm., 66: 1035-1038. PMID: 19451615
4. Gaeta, G., S. Lupoli, V. Brancaccio, L. Effuso and V. Russo et al., 1998. Anticardiolipin antibodies and early infarct of the myocardium. Cardiologia, 43: 731-5. PMID: 9738331
5. Hughes, G.R., 2010. Antiphospholipid syndrome (Hughes syndrome): 10 clinical topics. Lupus, 19: 343-346. PMID: 20353967
6. Hunt, J.E., H.P. McNeil, G.J. Morgan, R.M. Crameri and S.A. Krilis, 1992. A phospholipid beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus, 1: 75-81. PMID: 1301967
7. Lang, R.M., M. Bierig, R.B. Devereux F.A. Flachskampf and A. Foster et al., 2005. Quantification writing group; American society of echocardiography’s guidelines and standards committee; European association of echocardiography: Recommendations for chamber quantification: A report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J. Am. Soc. Echocardiogr., 18: 1440-14463. PMID: 16376782
8. Lopes-Virella, M.F., R.E. Carter, G.E. Gilbert, R.L. Klein and M. Jaffa et al., 2008. Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care, 31: 2006-2012. PMID: 18628568
9. McNeil, H.P., C.N. Chesterman and S.A. Krilis, 1991. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol., 49: 193-280. PMID: 1853785
10. McNeil, H.P., J.E. Hunt and S.A. Krilis, 1990. New aspects of anticardiolipin antibodies. Clin. Exp. Rheumatol., 8: 525-527. PMID: 2127002
11. Phadke, K.V., R.A. Phillips, D.T. Clarke, M. Jones and P. Naish et al., 1993. Anticardiolipin antibodies in ischaemic heart disease: Marker or myth? Br. Heart J., 69: 391-4. PMID: 8518060
12. Rebic, R., D. Nastic-Miric, S. Pavlovic, Z. Pokrajcic and V. Bosnjakovic, 1993. Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease. Med. Pregl. Suppl., 1: 20-22. PMID: 8569595
13. Saikku, P., M. Leinonen, K. Mattila, M.R. Ekman and M.S. Nieminen et al., 1988. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 2: 983-986. PMID: 2902492
14. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmaki and M.R. Ekman et al., 1992. Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann. Intern. Med., 116: 273-278. PMID: 1733381
15. Thom, D.H., S.P. Wang, J.T. Grayston, D.S. Siscovick and D.K. Stewart et al., 1991. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler. Thromb., 11: 547-551. PMID: 2029495
16. Thompson, S.G., J. Kienast, S.D.M. Pyke, F. Haverkate and J.C.W. Van de Loo, 1995. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N. Engl. J. Med., 332: 635-641. PMID: 7845427
17. Vaarala, O., 1991. Binding profiles of anticardiolipin antibodies in sera from patients with SLE and infectious diseases. J. Autoimmun., 4: 819-830. PMID: 1797029
18. Vaarala, O., M. Mänttäri, V. Manninen, L. Tenkanen, and M. Puurunen et al., 1995. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation, 91: 23-27. PMID: 7805207
19. Virella, G. and M.F. Lopes-Virella, 2008. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis, 200: 239-246. PMID: 18513726
20. Yilmaz, A.K. and C. Yilmaz, 1994. Importance of serum anticardiolipin antibody levels of coronary heart disease. Clin. Cardiol., 17: 117-121. PMID: 8168279
21. Zimmerman, F.H., A. Cameron and L.D. Fisher, 1995. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery study registry). J. Am. Coll. Cardiol., 26: 654-661. PMID: 7642855